dr. Behrouz Hassannia

Journal Article
A1
open access

Improving cardiac differentiation of human pluripotent stem cells by targeting ferroptosis

Jeffrey Aalders (UGent) , Laurens Léger (UGent) , Behrouz Hassannia (UGent) , Vera Goossens (UGent) , Tom Vanden Berghe (UGent) and Jolanda van Hengel (UGent)

(2024) REGENERATIVE THERAPY. 27. p.21-31

Add to list

Journal Article
A1
open access

Beyond ferrostatin-1 : a comprehensive review of ferroptosis inhibitors

Camilla Scarpellini, Greta Klejborowska, Caroline Lanthier, Behrouz Hassannia (UGent) , Tom Vanden Berghe (UGent) and Koen Augustyns

(2023) TRENDS IN PHARMACOLOGICAL SCIENCES. 44(12). p.902-916

Add to list

Journal Article
A1
open access

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

Emily Van San (UGent) , Angela Debruyne (UGent) , Geraldine Veeckmans, Yulia Y. Y. Tyurina, Vladimir A. A. Tyurin, Hao Zheng, Sze Men Choi (UGent) , Koen Augustyns, Geert van Loo (UGent) , Bernhard Michalke, et al.

(2023) CELL DEATH AND DIFFERENTIATION. 30(9). p.2092-2103

Add to list

Journal Article
A1
open access

Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells

Roberto Fernández-Acosta, Behrouz Hassannia (UGent) , Jurgen Caroen (UGent) , Bartosz Wiernicki (UGent) , Daniel Alvarez-Alminaque, Bruno Verstraeten (UGent) , Johan Van der Eycken (UGent) , Peter Vandenabeele (UGent) , Tom Vanden Berghe (UGent) and Gilberto L. Pardo-Andreu

(2023) CELLS. 12(5).

Add to list

Journal Article
A1
open access

Novel iron oxide nanoparticles induce ferroptosis in a panel of cancer cell lines

Roberto Fernandez-Acosta, Claudia Iriarte-Mesa, Daniel Alvarez-Alminaque, Behrouz Hassannia (UGent) , Bartosz Wiernicki (UGent) , Alicia M. Diaz-Garcia, Peter Vandenabeele (UGent) , Tom Vanden Berghe (UGent) and Gilberto L. Pardo Andreu

(2022) MOLECULES. 27(13).

Add to list

Luminescent human iPSC-derived neurospheroids enable modeling of neurotoxicity after oxygen-glucose deprivation

Elise Van Breedam, Aleksandra Nijak, Tamariche Buyle-Huybrecht, Julia Di Stefano, Marlies Boeren, Jonas Govaerts, Alessandra Quarta, Tine Swartenbroekx, Eva Jacobs, Björn Menten (UGent) , et al.

(2022) NEUROTHERAPEUTICS. 19(2). p.550-569

Add to list

Journal Article
A1
open access

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

Samya Van Coillie (UGent) , Emily Van San (UGent) , Ines Goetschalckx, Bartosz Wiernicki (UGent) , Banibrata Mukhopadhyay, Wulf Tonnus, Sze Men Choi (UGent) , Ria Roelandt (UGent) , Catalina Dumitrascu, Ludwig Lamberts, et al.

(2022) NATURE COMMUNICATIONS. 13(1).

Add to list

Journal Article
A1
open access

Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state

Farzaneh Ghazavi (UGent) , Jelle Huysentruyt (UGent) , Jordy De Coninck (UGent) , Stephanie Kourula (UGent) , Sofie Martens, Behrouz Hassannia (UGent) , Tim Wartewig, Tatyana Divert (UGent) , Ria Roelandt (UGent) , Bastian Popper, et al.

(2022) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 119(6).

Add to list

Ferroptosis : biological rust of lipid membranes

Behrouz Hassannia (UGent) , Samya Van Coillie (UGent) and Tom Vanden Berghe (UGent)

(2020) ANTIOXIDANTS & REDOX SIGNALING.

Add to list

Journal Article
A1
open access

Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis

Bartosz Wiernicki (UGent) , Hanne Dubois, Yulia Y. Tyurina, Behrouz Hassannia (UGent) , Hulya Bayir, Valerian E. Kagan, Peter Vandenabeele (UGent) , Andy Wullaert (UGent) and Tom Vanden Berghe (UGent)

(2020) CELL DEATH & DISEASE. 11(10).

Add to list

Withaferin A : from ayurvedic folk medicine to preclinical anti-cancer drug

Behrouz Hassannia (UGent) , Emilie Logie, Peter Vandenabeele (UGent) , Tom Vanden Berghe (UGent) and Wim Vanden Berghe

(2020) BIOCHEMICAL PHARMACOLOGY. 173.

Add to list

Targeting ferroptosis to iron out cancer

Behrouz Hassannia (UGent) , Peter Vandenabeele (UGent) and Tom Vanden Berghe (UGent)

(2019) CANCER CELL. 35(6). p.830-849

Add to list

Water-soluble Withaferin A polymer prodrugs via a drug-functionalized RAFT CTA approach

Simon Van Herck (UGent) , Behrouz Hassannia (UGent) , Benoit Louage (UGent) , Raquel Pita Compostizo, Ruben De Coen (UGent) , Wim Vanden Berghe (UGent) , Tom Vanden Berghe (UGent) and Bruno De Geest (UGent)

(2019) EUROPEAN POLYMER JOURNAL. 110. p.313-318

Add to list

Journal Article
A1
open access

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

Behrouz Hassannia (UGent) , Bartosz Wiernicki (UGent) , Irina Ingold, Feng Qu, Simon Van Herck (UGent) , Yulia Y. Tyurina, Hülya Bayır, Behnaz A. Abhari, Jose Pedro Friedmann Angeli, Sze Men Choi (UGent) , et al.

(2018) JOURNAL OF CLINICAL INVESTIGATION. 128(8). p.3341-3355

Add to list

PhD Thesis

Ferroptosis : triggers, inhibitors and therapeutic potential in neuroblastoma

Behrouz Hassannia (UGent)

(2016)

Add to list

A real-time fluorometric method for the simultaneous detection of cell death type and rate

Sasker Grootjans (UGent) , Behrouz Hassannia (UGent) , Iris Delrue (UGent) , Vera Goossens (UGent) , Bartosz Wiernicki (UGent) , Yves Dondelinger (UGent) , Mathieu Bertrand (UGent) , Dmitri Krysko (UGent) , Marnik Vuylsteke (UGent) , Peter Vandenabeele (UGent) , et al.

(2016) NATURE PROTOCOLS. 11(8). p.1444-1454

Add to list

Journal Article
A1
open access

An outline of necrosome triggers

Tom Vanden Berghe (UGent) , Behrouz Hassannia (UGent) and Peter Vandenabeele (UGent)

(2016) CELLULAR AND MOLECULAR LIFE SCIENCES. 73(11-12). p.2137-2152

Add to list

Novel ferroptosis inhibitors with improved potency and ADME properties

Sam Hofmans, Tom Vanden Berghe (UGent) , Lars Devisscher, Behrouz Hassannia (UGent) , Sophie Lyssens, Jurgen Joossens, Pieter Van Der Veken, Peter Vandenabeele (UGent) and Koen Augustyns

(2016) JOURNAL OF MEDICINAL CHEMISTRY. 59(5). p.2041-2053

Add to list

Book Chapter
open access

Phytochemicals and cancer chemoprevention: epigenetic friends or foe?

Katarzina Szarc vel Szic, Ajay Palagani (UGent) , Behrouz Hassannia (UGent) , Linde Sabbe (UGent) , Karen Heyninck (UGent) , Guy Haegeman (UGent) and Wim Vanden Berghe (UGent)

(2011) Phytochemicals : bioactivities and impact on health. p.159-198

Academic Bibliography

dr. Behrouz Hassannia

Improving cardiac differentiation of human pluripotent stem cells by targeting ferroptosis

Beyond ferrostatin-1 : a comprehensive review of ferroptosis inhibitors

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells

Novel iron oxide nanoparticles induce ferroptosis in a panel of cancer cell lines

Luminescent human iPSC-derived neurospheroids enable modeling of neurotoxicity after oxygen-glucose deprivation

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state

Ferroptosis : biological rust of lipid membranes

Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis

Withaferin A : from ayurvedic folk medicine to preclinical anti-cancer drug

Targeting ferroptosis to iron out cancer

Water-soluble Withaferin A polymer prodrugs via a drug-functionalized RAFT CTA approach

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

Ferroptosis : triggers, inhibitors and therapeutic potential in neuroblastoma

A real-time fluorometric method for the simultaneous detection of cell death type and rate

An outline of necrosome triggers

Novel ferroptosis inhibitors with improved potency and ADME properties

Phytochemicals and cancer chemoprevention: epigenetic friends or foe?

Contents

Support

Contact